Exogene
AI-designed T-cell receptor immunotherapies for patients with solid tumors
Highlights
- New on EvolcAdded 2026-11-14
About Exogene
Exogene develops T-cell receptor (TCR)-based immunotherapies for solid tumors. Its discovery platform combines generative AI with high-throughput TCR screening using full-length TCR yeast display, with experimental results feeding back into its models.
The company is based in London and was founded in 2019. Its multidisciplinary team works across computational biology, machine learning, protein science and therapeutic development.
Product: A discovery platform and TCR-based immunotherapy candidates for solid tumors, developed using generative AI and experimental screening.
Jobs at Exogene
More biotech & pharma companies
Exosla
Develops extracellular-vesicle immunotherapies for newborns with hypoxic brain injury and other immune-related diseasesNew on EvolcExtracellular
CDMO for cell-based food, cosmetics and materials products, offering bioprocess development and up to 2,000L manufacturingYoung companySalary transparentExymes
Enzyme-based DNA/RNA extraction reagents and kits for forensic, academic, veterinary and environmental labsYoung companyF2G
Develops medicines for patients with rare, life-threatening fungal infectionsFabricnano
Enzyme immobilization technology for industrial companies developing cell-free biomanufacturing processesNew on EvolcFast MDX
Automated molecular diagnostic testing platform for clinical and pathology laboratoriesNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content management
- ElementorHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- nginxHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.